These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 15522281

  • 1. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y, Ahmad N, Wani MA, Ashraf M.
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [Abstract] [Full Text] [Related]

  • 2. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y, Takemura G, Kosai K, Yuge K, Nagano S, Esaki M, Goto K, Takahashi T, Hayakawa K, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Mizuguchi H, Fujiwara T, Fujiwara H.
    Circulation; 2003 May 20; 107(19):2499-506. PubMed ID: 12695295
    [Abstract] [Full Text] [Related]

  • 3. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.
    J Cardiovasc Pharmacol; 2009 Dec 20; 54(6):510-9. PubMed ID: 19755919
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K, Kodama I.
    Cardiovasc Res; 2010 Apr 01; 86(1):113-21. PubMed ID: 19969622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
    Tang J, Wang J, Kong X, Yang J, Guo L, Zheng F, Zhang L, Huang Y, Wan Y.
    Exp Cell Res; 2009 Dec 10; 315(20):3521-31. PubMed ID: 19800880
    [Abstract] [Full Text] [Related]

  • 11. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H.
    J Pharmacol Exp Ther; 2008 Jun 10; 325(3):741-50. PubMed ID: 18334667
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S.
    Circulation; 2009 Sep 15; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [Abstract] [Full Text] [Related]

  • 13. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH, Wu GF, Wang XQ, Yang YH, Du ZM, He XH, Xiang P.
    Chin Med J (Engl); 2006 Sep 20; 119(18):1499-506. PubMed ID: 16996002
    [Abstract] [Full Text] [Related]

  • 14. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y, Sawa Y, Takewa Y, Tatsumi E, Kaneda Y, Taenaka Y, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Sep 20; 130(3):624-32. PubMed ID: 16153905
    [Abstract] [Full Text] [Related]

  • 15. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J, Gardner TJ, Sweeney HL.
    J Card Surg; 2005 Sep 20; 20(1):93-101. PubMed ID: 15673421
    [Abstract] [Full Text] [Related]

  • 16. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE, Ikeda U.
    Circ Res; 2006 Oct 13; 99(8):891-9. PubMed ID: 16990567
    [Abstract] [Full Text] [Related]

  • 17. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction.
    Zou Y, Takano H, Mizukami M, Akazawa H, Qin Y, Toko H, Sakamoto M, Minamino T, Nagai T, Komuro I.
    Circulation; 2003 Aug 12; 108(6):748-53. PubMed ID: 12860906
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
    Zaruba MM, Huber BC, Brunner S, Deindl E, David R, Fischer R, Assmann G, Herbach N, Grundmann S, Wanke R, Mueller-Hoecker J, Franz WM.
    Cardiovasc Res; 2008 Mar 01; 77(4):722-31. PubMed ID: 18055578
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T, Miura T, Nishino Y, Yano T, Sakamoto J, Nakamura Y, Ichikawa Y, Ikeda Y, Kobayashi H, Ura N, Shimamoto K.
    Clin Exp Pharmacol Physiol; 2004 Dec 01; 31(12):873-82. PubMed ID: 15659052
    [Abstract] [Full Text] [Related]

  • 20. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Xu ZQ, Zhang FM, Cao KJ, Ma WZ.
    Gene Ther; 2006 Nov 01; 13(22):1564-8. PubMed ID: 16810195
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.